clinical trial · NCT01135108
Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Spinal Cord Injury
Spinal Cord InjuryPlaceboKAI-1678
brief summary
The purpose of this study is to determine whether KAI-1678 is effective in the treatment of pain associated with spinal cord injury.
started
Mar 1, 2009
primary completion
Mar 1, 2010
completion
May 1, 2010
last updated
Sep 2, 2025
official title
A Double-Blind, Randomized, Placebo-Controlled, Single-Dose Two-Period Crossover Study to Assess the Efficacy of KAI-1678 Administered by Subcutaneous Infusion in Subjects With Spinal Cord Injury
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol